Akebia Therapeutics (AKBA) Debt Ratio (2018 - 2025)
Akebia Therapeutics (AKBA) has disclosed Debt Ratio for 7 consecutive years, with 0.18 as the latest value for Q4 2024.
- On a quarterly basis, Debt Ratio rose 22.2% to 0.18 in Q4 2024 year-over-year; TTM through Dec 2024 was 0.18, a 22.2% increase, with the full-year FY2024 number at 0.18, up 22.2% from a year prior.
- Debt Ratio was 0.18 for Q4 2024 at Akebia Therapeutics, down from 0.19 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.19 in Q4 2022 to a low of 0.1 in Q1 2020.
- A 5-year average of 0.16 and a median of 0.16 in 2021 define the central range for Debt Ratio.
- Peak YoY movement for Debt Ratio: surged 59.11% in 2021, then dropped 25.33% in 2024.
- Akebia Therapeutics' Debt Ratio stood at 0.15 in 2020, then increased by 23.16% to 0.18 in 2021, then increased by 0.71% to 0.19 in 2022, then decreased by 22.68% to 0.14 in 2023, then rose by 22.2% to 0.18 in 2024.
- Per Business Quant, the three most recent readings for AKBA's Debt Ratio are 0.18 (Q4 2024), 0.19 (Q3 2024), and 0.13 (Q1 2024).